Axt projects Q4 non-GAAP EPS of $0.57-$0.59 as backlog moves above $500M

• "Our financial results highlight the continuing inflection in our business trajectory and the early stages of a multiyear growth phase for AXT." (CFO, VP & Corporate Secretary Gary Fischer)
• "Revenue for the third quarter of 2026 was $73.4 million." (CFO Fischer)
• "To break down our Q3 '26 revenue for you by product category, indium phosphide was $54.3 million... Gallium arsenide was $9.1 million... Finally, revenue from our consolidated raw material companies in Q3 was $9.7 million." (CFO Fischer)
• "Non-GAAP gross margin was 56.1%" and "we are pleased to report a non-GAAP net profit of $26.8 million or $0.41 per diluted share." (CFO Fischer)
• "During Q3, we signed a long-term supply agreement with Lumentum" and "we received a prepayment for wafers of $43.5 million." (CFO Fischer)
• "Yesterday, we announced that our majority-owned subsidiary, Tongmei, has entered into a definitive agreement for a private equity financing" and "assuming the maximum amount of the investment at USD 545 million, AXT will maintain control of Tongmei with approximately 73.4% ownership, down approximately 12.1% following the completion of the transaction." (CFO Fischer)
• "This is a pivotal and exciting period for AXT" and "we surpassed that goal in August" referring to its plan to double indium phosphide capacity in 2026. (Co-Founder, CEO & Chairman Morris Young)
• "We are in a brand-new territory with backlog now above $500 million, including long-term multiyear agreements, short-term contracts of less than 12 months and spot purchase orders." (CEO Young)
• "Case in point, we continue to make great strides in development of our 6-inch indium phosphide capability" and "our 6-inch lines are now moving to power production status with productivity increasing steadily." (CEO Young)

Outlook

• "As of today, we have approximately $90 million in revenue that can be realized in Q4 across our substrate product lines and raw materials for which we either already have a permit to ship or for which a permit is not required." (CFO Fischer)
• "With regards to operating expense, we expect that it will be approximately $13 million in Q4 on a non-GAAP basis and approximately $14 million on a GAAP basis." (CFO Fischer)
• "We believe our non-GAAP net income will be in the range of $0.57 to $0.59 and GAAP net income will be in the range of $0.56 to $0.58." (CFO Fischer)
• "We estimate the share count for Q4 will be approximately 66.1 million shares." (CFO Fischer)
• "Further improvement depends on a number of factors, including total revenue as it relates to revenue mix by product, absorption of fixed costs and our ability to continue to drive better manufacturing efficiency." (CFO Fischer)
• "As of today, we have approximately $66 million in revenue that can be realized in Q3" and "we believe our non-GAAP net income will be in the range of $0.30 to $0.32" were the prior-quarter guide points management used for context. (CFO Fischer, Q2 call)

Financial Results

• "Non-GAAP gross margin was 56.1% compared with 45.0% gross margin in Q2" and "market prices for indium phosphide have increased and a shift from 3-inch to 4-inch wafers has also contributed." (CFO Fischer)
• "Our total non-GAAP operating expense in Q3 was $11.7 million compared with $10.2 million in Q2." (CFO Fischer)
• "Nonoperating income and expense and other items below the line of the operating line for the third quarter of 2026 was a net loss of $2.7 million." (CFO Fischer)
• "Cash, cash equivalents and investments increased by $77 million to $825.9 million as of September 30." (CFO Fischer)
• "In Q3, DSO improved to 49 days as a result of multiple customer prepayments." (CFO Fischer)

Q&A

• Richard Shannon, Craig-Hallum: "I’d love for you to discuss gross margins" and "whether it can go up meaningfully from here"; CFO Fischer: "I do think our gross margin will go up some more. I don't think we've peaked -- and I think it's reasonable to expect that it could begin with a 6 in the next quarter."
• Richard Shannon, Craig-Hallum: asked for updated indium phosphide revenue capacity potential; VP of Business Development Timothy Bettles: "In Q3, we recorded an indium phosphide revenue of $54.3 million, and that's probably going to go up in Q4" and "Total projection of Q4 being around the $90 million mark... all of the growth is going to be indium phosphide."
• Charles Shi, Needham: raised "worried about AXT adding a good amount of capacity and that could lead to overcapacity"; VP Bettles: "we are significantly overbooked. All of our customers are on allocation" and "It is impossible to keep up with demand."
• Charles Shi, Needham: asked whether Lumentum was a second agreement and about the jump in backlog; VP Bettles: "the Lumentum contract is the contract that we signed in Q3" and "we've surpassed the $500 million barrier."
• Tim Savageaux, Northland: asked whether 60% gross margin is a "new baseline"; CFO Fischer: "it's pretty obvious that we're going to cross over 60%" but "we're hesitant to predict because things are moving so fast."
• Matt Bryson, Wedbush: asked for mix and competitive positioning on 4-inch/6-inch; VP Bettles: "a lot of the laser material is now going to also transition to 4-inch" and "towards the end of the year, we could be looking... something equal in 3-inch and 4-inch by the end of the year" (referring to 2027), while CEO Young added on 6-inch: "other than Us, there's a company called Us, and they are probably now equal to us. And the third is a very distant third."
• Matt Bryson, Wedbush: asked if doubling indium phosphide capacity in 2027 remains the framework; CFO Fischer: "our goal is to double again in 2027."

Sentiment Analysis

• Analysts were slightly positive and increasingly focused on sustainability of margins and capacity risk, with questions like "how high they could go" (Richard Shannon, Craig-Hallum) and "overcapacity" concerns (Charles Shi, Needham).
• Management tone was positive in prepared remarks and confident in Q&A, using phrasing such as "we are significantly overbooked" (VP Bettles) and "I don't think we've peaked" (CFO Fischer), while also signaling caution on forecasting with "we're hesitant to predict because things are moving so fast" (CFO Fischer).
• Versus the prior quarter, management’s margin language tightened from "We should definitely be targeting a number that begins with the 5" (CFO Fischer, Q2 call) to "it could begin with a 6 in the next quarter" (CFO Fischer, Q3 call), while analysts shifted from export-permit process questions (Q2) toward durability of elevated gross margin and competitive supply response (Q3).

Quarter-over-Quarter Comparison

• Backlog visibility language stepped up from "backlog that continues to grow and now is well over $100 million" (CEO Young, Q2 call) to "backlog now above $500 million" (CEO Young, Q3 call).
• Margin discussion moved from expectation-setting to higher realized levels, from "Non-GAAP gross margin was 45.0%" (CFO Fischer, Q2 call) to "Non-GAAP gross margin was 56.1%" (CFO Fischer, Q3 call), with Q3 management explicitly pointing to 4-inch migration, productivity, and pricing.
• Capital and strategic actions expanded from Q2’s focus on the secondary offering proceeds ("generated approximately $632 million" before expenses) (CFO Fischer, Q2 call) to Q3’s focus on customer prepayments and Tongmei financing/IPO path, including "a definitive agreement for a private equity financing" tied to expanding indium phosphide and raw material capacity. (CFO Fischer, Q3 call)
• Analyst emphasis shifted from Q2 permit cadence ("more regularity in the process") (VP Bettles, Q2 call) to Q3 concerns about market structure (allocation, overcapacity, and competitive differentiation in low EPD and 6-inch readiness). (VP Bettles and CEO Young, Q3 call)

Risks and Concerns

• "Further improvement depends on a number of factors" including "revenue mix by product" and "our ability to continue to drive better manufacturing efficiency." (CFO Fischer)
• "Assuming the maximum amount of the investment at USD 545 million, AXT will maintain control of Tongmei with approximately 73.4% ownership" implying dilution at the subsidiary level while funding expansion. (CFO Fischer)
• "Demand remains ahead of supply even as we accelerate the pace of our capacity addition." (CEO Young)
• "It is impossible to keep up with demand" and "every customer is on allocation" were management’s responses to investor concerns about supply/demand balance and potential overcapacity. (VP Bettles)

Final Takeaway

AXT’s management framed Q3 as an acceleration of its indium phosphide-driven inflection, highlighting record profitability metrics, a backlog "now above $500 million," and increased customer commitment signaled by a $43.5 million Lumentum prepayment. For Q4, the company guided to approximately $90 million of realizable revenue and non-GAAP net income of $0.57 to $0.59, while emphasizing that additional gross margin improvement depends on volume, mix, and ongoing productivity gains. Management also underscored Tongmei’s planned private equity financing—up to $545 million—to fund capacity expansion as it advances toward a Hong Kong listing, positioning supply expansion as the operational priority amid continued allocation and demand exceeding supply.

Read the full Earnings Call Transcript

Seeking Alpha's Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.